Help
Login
Busy
Search
International Patient Summary (IPS) - Issues

 
Select object
 
false
Results (1 / 1)
Id Issue Status Priority Type Date Assigned To Label
9 SBADM effective time: IVL_TS or IVL_TS and TS Closed Normal Request for Information/Education 2017-04-11 15:37:15
 
 Meds 
 
 CDA 
 
 IHE 
 
 eHDSI 
 
Request for Information/Education SBADM effective time: IVL_TS or IVL_TS and TS
Id hl7ips-issue-9
Status Closed
Priority Normal
Last Tracking 2017-04-11 15:37:15  by  Giorgio Cangioli
Current Labels
    
 (Meds) Medications 
    
 (CDA) CDA Implementation 
    
 (IHE) For IHE consideration 
    
 (eHDSI) For eHDSI consideration 
    
Concerns
Template
false
IPS Medication Statement (hl7ips-entry-template-4)
/
/
Template 2.16.840.1.113883.10.22.4.4 (2016-11-11) IPS Medication Statement
Status Under pre-publication review
/
-
/
-
Events
Tracking Closed 2017-04-11 15:37:15 : Tracking by Giorgio Cangioli
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Description
Solution identified (subordinate SBADM) and applied for the medication template entry
Tracking Feedback needed 2017-02-15 16:54:47 : Tracking by Giorgio Cangioli
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Description
Call 2017/02/08
Use the approach proposed by the Pharma WG.
Tracking In Progress 2017-02-03 21:10:35 : Tracking by Rob Hausam
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Description
Kai, is there documentation (minutes or otherwise) from the Pharmacy WG on this that we can reference for this?  The minutes from San Antonio aren't showing as available yet on the Wiki.
Tracking In Progress 2017-02-03 18:59:07 : Tracking by Dr. Kai Heitmann
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Description
HL7 International Pharmacy Work Group (where I am a member of) had discussed this issue in San Antonio. Re/ “Medication on CDA” the Pharmacy WG says:
  • There is only one effectiveTime element in the SubstanceAdministration Act that reflects the period of administration (usable period), data type IVL_TS, maybe nullFlavored or omitted
  • All other dosage information (frequency) goes always into subordinate SubstanceAdminstration Acts. 
One important rational came from vendors implementing Medication related stuff. They definitely prefer to find dosage information always at the same location and not – like in IHE as of now – sometimes here and sometimes there. The data types of these elements are pre-defined. This also applies to single shots, tapered dose, split dose.
 
I advise to go that direction and not to make any other decisions. I think this solves every concern we had.
Tracking In Progress 2017-02-03 17:14:53 : Tracking by Giorgio Cangioli
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Description
to be better understood the meaning of two effectiveTime linked by an "A" operator in which one of the two elements is nullFlavored.

That is the itersection of an undefined with a defined set is undefined ......
Tracking In Progress 2017-01-10 13:14:39 : Tracking by Giorgio Cangioli
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Edited by Giorgio Cangioli ( 2017-02-01 15:51:31 )
Description
I don't see a different meaning : the first one is when you get / will get medications; the second one the frequency of intake.

The question was how to deal when we have one shot administration:
(a) should we have a first effectiveTime with an interval with low and high equal set to a specific datetime and a second effective time with datatype TS  set to that datetime;
(b) or have simply only one effectiveTime with datatype TS  set to a specific datetime.

The first one is the solution adopted by IHE PCC the second one by C-CDA (as far as i can understand).

I've no strong opinion on this...so i leave the choice to the group... :-)
Tracking Open 2017-01-09 18:32:00 : Tracking by Dr. Kai Heitmann
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Description
Hmm, the meaning of the two effectiveTimes is different. Here is what many implementations do:
  • First effectiveTime is the use period, e.g. take these medication from 1-10 January 2017. It is always an interval. If not specified this first effectiveTime shall be nullFlavored.
  • The second effectiveTime is the frequency pattern, like two times a day, once a week etc. This must be optional as e.g. tapered or split dose specifications will cause the need to specify the patterns in subsequent substanceAdministrations (see the entryRelationship in this template).
If I may I strongly suggest to follow that rule. It is by the way conformant with what we at the Pharmacy Workgroup HL7 International defined in the "Medication in CDA" project.
Furthermore you can find these definitions in ELGA:
  • SBADM http://art-decor.org/art-decor/decor-templates--elgabbr-?section=templates&id=1.2.40.0.34.11.8.1.3.1&effectiveDate=2014-09-01T00:00:00
  • Use Period http://art-decor.org/art-decor/decor-templates--elgabbr-?id=1.2.40.0.34.11.30006&effectiveDate=dynamic
or in IHE (as defined by the Swiss colleagues)
  • http://art-decor.org/art-decor/decor-templates--cdachemed-?section=templates&id=2.16.756.5.30.1.1.1.1.3.10.2.10.2.10.4.1&effectiveDate=2016-06-25T00:00:00
  • http://art-decor.org/art-decor/decor-templates--cdachemed-?id=2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.1&effectiveDate=dynamic
Thanks
Tracking Open 2017-01-09 18:05:23 : Tracking by Giorgio Cangioli
    
 Meds 
    
 CDA 
    
 IHE 
    
 eHDSI 
Edited by Giorgio Cangioli ( 2017-01-09 18:06:20 )
Description
Call 20161228
allow for both IVL_TS and TS

in the second case (TS) the second effectiveTime is not required
Tracking Open 2016-11-15 15:10:10 : Tracking by Giorgio Cangioli
    
 Meds 
    
 CDA 
Tracking Open 2016-11-11 10:17:23 : Tracking by Giorgio Cangioli
Description
Finding:

IHE PCC template (and the epSOS one) requests that the first effective time is an IVL_TS (not demoted to TS)
C-CDA allow both IVL_TS and TS

What we would like to do here and why ?

Suggestion:

-

Further explanation:

-

    
Labels
Preview Code HTML color Display Name Description
 
 STU1Ballot 
STU1Ballot STU1Ballot STU1 Ballot
 
 TBD 
TBD TBD To be discussed
 
 Vocab 
Vocab Vocab Vocabularies
 
 CCDA 
CCDA CCDA For CCDA consideration
 
 eHDSI 
eHDSI eHDSI For eHDSI consideration
 
 IHE 
IHE IHE For IHE consideration
 
 Meds 
Meds Meds Medications
 
 Allergy 
Allergy Allergy Allergy
 
 CDA 
CDA CDA CDA Implementation
 
 DataSet 
DataSet DataSet Data Set